Using shock wave therapy to treat spastic equinus foot in stroke patients
Effects of Focused Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients: a Randomized Controlled Trial
This study is testing whether one or three sessions of shock wave therapy can help stroke patients with tight calf muscles and improve their movement and quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana Academic / other |
| Locations | 1 site (Vila-real, Castellon) |
| Trial ID | NCT06547684 on ClinicalTrials.gov |
What this trial studies
This study evaluates the long-term effects of focused extracorporeal shock wave therapy (fESWT) on spasticity in stroke patients with equinus foot. It involves a randomized controlled trial with 60 participants, who will be divided into two groups: one receiving 1 session of fESWT and the other receiving 3 sessions over three weeks. The therapy targets the gastrocnemius and soleus muscles, and outcomes will be measured using various scales to assess spasticity, mobility, and quality of life. The goal is to determine if multiple sessions provide better long-term benefits than a single session.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who have experienced a stroke at least 6 months prior and have spastic equinus foot.
Not a fit: Patients with fixed ankle joint contractures, severe medical issues, or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly improve mobility and quality of life for stroke patients suffering from spastic equinus foot.
How similar studies have performed: Previous studies have shown positive effects of extracorporeal shock wave therapy on spasticity, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than 18 years old * Time from stroke (ischemic o hemorrhagic) onset of at least 6 months * Spastic equinus foot: triceps surae tone grade at least 1+ on the MAS score * Ability to walk alone with or without aids Exclusion Criteria: * Fixed ankle joint contracture * Severe medical problems * Treatment of the affected leg with botulinum toxin in the las 6 months * Cognitive impairment
Where this trial is running
Vila-real, Castellon
- Hospital de la Plana — Vila-real, Castellon, Spain (Recruiting)
Study contacts
- Principal investigator: Teresa Mª Mateu Campos — Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
- Study coordinator: Teresa Mª Mateu Campos
- Email: teremateuc@gmail.com
- Phone: +34666803771
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.